Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2052435

C=CCNC(C)(C)O.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropyl Alcohol SCHEMBL10358892 0.88 HTT (0.32)
Hydrochloric Acid SCHEMBL29191276 0.84
SCHEMBL1007132 0.81
Hydrochloric Acid SCHEMBL4259392 0.78
Hydrochloric Acid SCHEMBL4561506 0.78
Hydrochloric Acid SCHEMBL27450224 0.76
Hydrochloric Acid SCHEMBL5964776 0.75 ALDH1A1 (0.38)
SCHEMBL4263479 0.75
SCHEMBL31088682 0.75 ALDH1A1 (0.31)
SCHEMBL1234538 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117126544-B Compound emulsified asphalt, and preparation and application thereof 湖南云中再生科技股份有限公司 2024-03-29 CN claimed
CN-117126544-A Compound emulsified asphalt, and preparation and application thereof 湖南云中再生科技股份有限公司 2023-11-28 CN claimed
US-7015180-B2 Hair treatment compositions comprising an anionic surfactant and a C8-C22 alkyl dimethyl hydroxyethyl ammonium chloride CLARIANT S.A. (BR) 2006-03-21 US claimed
CN-116546890-A Liquid composition comprising cereal beta-glucan or cereal extract containing beta-glucan 西姆莱斯股份公司 2023-08-04 CN disclosed
US-11191795-B2 Herbal compositions and methods for treating herpes CARRASCO NINO BEATRIZ EUGENIA (US) 2021-12-07 US disclosed
US-20200261522-A1 HERBAL COMPOSITIONS AND METHODS FOR TREATING HERPES CARRASCO NIÑO BEATRIZ EUGENIA (US) 2020-08-20 US disclosed
EP-2544662-B1 FOAMABLE FORMULATION NUVO PHARMACEUTICALS INC (CA) 2020-05-20 EP disclosed
US-10646441-B2 Foamable formulation NUVO PHARMACEUTICALS INC. (CA) 2020-05-12 US disclosed
US-20180147144-A1 FOAMABLE FORMULATION NUVO PHARMACEUTICALS INC. (CA) 2018-05-31 US disclosed
US-9861579-B2 Foamable formulation NUVO PHARMACEUTICALS INC. (CA) 2018-01-09 US disclosed
US-20150342871-A1 HIGHLY PERMEATING TERBINAFINE FORMULATION CRESCITA THERAPEUTICS INC. (CA) 2015-12-03 US disclosed
US-20130243701-A1 FOAMABLE FORMULATION NUVO RESEARCH INC. (CA) 2013-09-19 US disclosed
EP-2544662-A2 FOAMABLE FORMULATION Nuvo Research Inc. (CA) 2013-01-16 EP disclosed
EP-2544659-A2 HIGHLY PERMEATING TERBINAFINE FORMULATION FOR TREATING ONYCHOMYCOSIS Nuvo Research Inc. (CA) 2013-01-16 EP disclosed
US-20120309843-A1 HIGHLY PERMEATING TERBINAFINE FORMULATION NUVO RESEARCH INC. (CA) 2012-12-06 US disclosed
WO-2011112875-A2 FOAMABLE FORMULATION NUVO RESEARCH INC. (CA) 2011-09-15 WO disclosed
WO-2011079234-A2 HIGHLY PERMEATING TERBINAFINE FORMULATION NUVO RESEARCH INC. (CA) 2011-06-30 WO disclosed
US-4931271-A HAIR CONDITIONERS, DYES, SHAMPOOS, PERMANENT WAVES; SKIN CREAMS WELLA AKTIENGESELLSCHAFT (DE) 1990-06-05 US disclosed
US-4277581-A HAIR CONDITIONERS L'OREAL (FR) 1981-07-07 US disclosed
US-4189468-A Crosslinked polyamino-polyamide in hair conditioning compositions L'OREAL (FR) 1980-02-19 US disclosed